Status:
COMPLETED
Post Marketing Surveillance of Alesion® in Japanese Paediatric Patients With Allergic Rhinitis, Eczema/Dermatitis, Urticaria and Pruritus
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Rhinitis, Allergic, Perennial
Eligibility:
All Genders
Brief Summary
Study to investigate the safety and efficacy of Alesion® Dry Syrup under the proper use in daily clinical practice in Japanese paediatric patients with allergic rhinitis, eczema/dermatitis, urticaria ...
Eligibility Criteria
Inclusion
- All the patients who:
- haven't treatment experience of epinastine product;
- have at least one out of following diseases. allergic rhinitis, eczema, dermatitis, pruritus, urticaria
Exclusion
- Alesion® Dry Syrup is contraindicated for the patients with history of hypersensitivity to any ingredients of Alesion® Dry Syrup in package insert. However, it was unknown whether a patient was hypersensitive to the ingredients of the product in almost cases. And this survey was drug utilization study to observe actual use in any patients. Therefore exclusion criteria are not set in the protocol
Key Trial Info
Start Date :
May 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
3793 Patients enrolled
Trial Details
Trial ID
NCT02238236
Start Date
May 1 2005
Last Update
September 12 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.